INSTYLLA
Live / Applied — Statement of use — response to non-final action entered (as of 10 Mar 2026)
What this means for you
Not registered yet, but its 11 Sept 2020 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90174509
- Mark type
- Design + words
- Filed
- 11 Sept 2020
- Published for opposition
- 18 Mar 2025
- Attorney of record
- William Anderson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for medical and surgical purposes in the nature of implantable materials, namely, pliable, synthetic hydrogel; pharmaceutical preparations for embolization therapy in interventional radiology and oncology in the nature of implantable materials, namely, pliable, synthetic hydrogel
- Class 010 — Medical apparatus: Embolic devices for treating anomalous vasculature of the body; medical device, namely, arterial embolectomy device; embolic device for embolization therapy in interventional radiology and oncology; embolic devices for interventional radiology, namely, interventional oncology and peripheral hemostasis; embolic devices for interventional radiology, namely, differentiated liquid embolics; embolic device for vascular embolization procedures; embolic device used for embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, control of bleeding due to disease or trauma, organs and segmental embolizations; embolic devices, namely, syringes and delivery catheters containing embolic agents delivered through a microcatheter under fluoroscopic control; kits for use in embolization procedures comprised of precursors that react to form a hydrogel when combined with each other and applicators therefore; medical apparatus, namely, system for vascular embolization procedures; embolic devices for vascular embolization, hemorrhage control, and peripheral hemostasis, namely, embolization therapy system featuring hydrogel precursors and applicator; kits for vascular embolization procedures, featuring hydrogel precursors and applicator
Owner
- Instylla, Inc., Bedford, MA, US
- Instylla, Inc., Bedford, MA, US
Prosecution history
- 10 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Mar 2026 — ASSIGNED TO LIE
- 03 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 02 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 02 Jan 2026 — NON-FINAL ACTION E-MAILED
- 02 Jan 2026 — SU - NON-FINAL ACTION - WRITTEN
- 08 Dec 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 11 Jun 2025 — USE AMENDMENT FILED
- 08 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Jun 2025 — TEAS STATEMENT OF USE RECEIVED
- 13 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Mar 2025 — PUBLISHED FOR OPPOSITION
- 12 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED